Comparison of effectiveness and safety of lasmiditan and CGRP-antagonists for the acute treatment of migraine in adults: systematic review and network meta-analysis of randomised trials

Nav

General Info

Geography

Global

Coverage type

Global

Time period covered

01/2014 - 12/2023

Data type

Scientific literature

Keywords

Migraine

Citation

Authors

Deng X, Zhou L, Liang C, Shang X, Hui X, Liu W, Liang S, Wang Y, Xu M, Guo K, Yang K, Li X

Journal

J Headache Pain

Volume

Issue

Pages

Publication year

2024

Suggested citation

Deng X, Zhou L, Liang C, Shang X, Hui X, Liu W, Liang S, Wang Y, Xu M, Guo K, Yang K, Li X. Comparison of effectiveness and safety of lasmiditan and CGRP-antagonists for the acute treatment of migraine in adults: systematic review and network meta-analysis of randomised trials. J Headache Pain. 2024; 25(1): 16.

DOI

101186s10194024017234

PMID

38311738

GHDx Entry last modified on: Mar 25, 2025

Header sites

Search form

Main menu

Comparison of effectiveness and safety of lasmiditan and CGRP-antagonists for the acute treatment of migraine in adults: systematic review and network meta-analysis of randomised trials

Nav